 |
PRI - Pharmaceutical Research Institute in Warsaw, Poland,
offers a comprehensive technology development and commercialization of medicinal products (API synthesis, drug dosage form,
analytical services, registration). Research and development activities of Pharmaceutical Research Institute concern
both generic and original, innovative drugs. PRI cooperates with pharmaceutical companies as well as scientific
institutions. The research and development files are prepared according to the current regulatory requirements (GMP,
GLP).
0.2 MB
Offer of Pharmaceutical Research Institute
Our research and development offer:
- Chemical synthesis: literature survey, development of
technologies in a laboratory as well as multigram scale, optimization of particular synthesis steps, preparation of
the samples of pharmaceutical purity.
- Active pharmaceutical ingredient (API) manufacturing technology:
process planning, development of technology (including the synthesis of new polymorphic forms), technology implementation.
- Analytics of active pharmaceutical ingredient (API) and drug form:
certification, development and validation of analytical methods, impurity profiles, physico-chemical research, structural research, polymorphism of active pharmaceutical ingredients (included in the drug form), stability studies, pharmaceutical availability studies.
- Drug form technology: development of drug dosage form technologies at laboratory and ¼-plant scale, troubleshooting assistance at each stage of technology development, ongoing technology modification.
- Bioavailability and bioequivalence studies: study plan, development and validation of the analytical method, pharmacokinetic parameters calculation, statistical analysis.
Manufacturing offer:
Other services:
Please feel invited to enter into a successful cooperation with our company
|
 |